Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2S congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes

European Journal of Immunology

Volumn 34, Issue 7, 2004, Pages 1828-1838

  Greve, Bernhard ^a   Reddy, Jayagopala ^a   Waldner, Hans Peter ^a   Sobel, Raymond A ^b,c   Kuchroo, Vijay K ^a  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; EAE MS; MHC; Rodent; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOLIPID PROTEIN; HISTOCOMPATIBILITY ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BACKCROSSING; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE RESISTANCE; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HYPOTHESIS; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIALOADENITIS; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ANIMALS, CONGENIC; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOPHOSPHAMIDE; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MYELIN PROTEOLIPID PROTEIN; T-LYMPHOCYTES;

EID: 3442901672     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425116     Document Type: Article

References (34)

1. Wanstrat, A. and Wakeland, E., The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2001. 2: 802-809.
2. Encinas, J. A. and Kuchroo, V. K., Mapping and identification of autoimmunity genes. Curr. Opin. Immunol. 2000. 12: 691-697.
3. Weissert, R., Wallstrom, E., Storch, M. K., Stefferl, A., Lorentzen, J., Lassmann, H., Linington, C. and Olsson, T., MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 1998. 102: 1265-1273.
4. Butterfield, R. J., Sudweeks, J. D., Blankenhorn, E. P., Korngold, R., Marini, J. C., Todd, J. A., Roper, R. J. and Teuscher, C., New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 1998. 161: 1860-1867.
5. Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W., Sudweeks, J., Rose, J. and Teuscher, C., Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 1999. 162: 3096-3102.
6. Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W. and Teuscher, C., Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am. J. Pathol. 2000. 157: 637-645.
7. Encinas, J. A., Lees, M. B., Sobel, R. A., Symonowicz, C., Greer, J. M., Shovlin, C. L., Weiner, H. L., Seidman, C. E., Seidman, J. G. and Kuchroo, V. K., Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 1996. 157: 2186-2192.
8. Dahlman, I., Wallstrom, E., Weissert, R., Storch, M., Kornek, B., Jacobsson, L., Linington, C., Luthman, H., Lassmann, H. and Olsson, T., Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 1999. 8: 2183-2190.
9. Becanovic, K., Wallstrom, E., Kornek, B., Glaser, A., Broman, K. W., Dahlman, I., Olofsson, P., Holmdahl, R., Luthman, H., Lassmann, H. and Olsson, T., New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 2003. 170: 1062-1069.
10. Kuchroo, V. K., Sobel, R. A., Yamamura, T., Greenfield, E., Dorf, M. E. and Lees, M. B., Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Pathobiology 1991. 59: 305-312.
11. Greer, J. M., Sobel, R. A., Sette, A., Southwood, S., Lees, M. B. and Kuchroo, V. K., Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 1996. 156: 371-379.
12. Anderson, A. C., Nicholson, L. B., Legge, K. L., Turchin, V., Zaghouani, H. and Kuchroo, V. K., High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 2000. 191: 761-770.
13. Encinas, J. A., Wicker, L. S., Peterson, L. B., Mukasa, A., Teuscher, C., Sobel, R., Weiner, H. L., Seidman, C. E., Seidman, J. G. and Kuchroo, V. K., QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing II2. Nat. Genet. 1999. 21: 158-160.
14. Johansson, A. C., Lindqvist, A. K., Johannesson, M. and Holmdahl, R., Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse. Scand. J. Immunol. 2003. 57: 203-213.
15. Slavin, A., Ewing, C., Liu, J., Ichikawa, M., Slavin, J. and Bernard, C. C., Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 1998. 28: 109-120.
16. Wicker, L. S., Appel, M. C., Dotta, F., Pressey, A., Miller, B. J., DeLarato, N. H., Fischer, P. A., Boltz, R. C., Jr. and Peterson, L. B., Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 1992. 176: 67-77.
17. Robinson, C. P., Yamachika, S., Bounous, D. I., Brayer, J., Jonsson, R., Holmdahl, R., Peck, A. B. and Humphreys-Beher, M. G., A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum. 1998. 41: 150-156.
18. Rasooly, L., Burek, C. L. and Rose, N. R., Iodine-induced autoimmune thyroiditis in NOD-H-2 h4 mice. Clin. Immunol. Immunopathol. 1996. 81: 287-292.
19. Johansson, A. C., Sundler, M., Kjellen, P., Johannesson, M., Cook, A., Lindqvist, A. K., Nakken, B., Bolstad, A. I., Jonsson, R., Alarcon-Riquelme, M. and Holmdahl, R., Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcαRIIb and is not associated with loci controlling diabetes. Eur. J. Immunol. 2001. 31: 1847-1856.
20. Ridgway, W. M., Ito, H., Fasso, M., Yu, C. and Fathman, C. G., Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J. Exp. Med. 1998. 188: 2267-2275.
21. Bhatnagar, A., Milburn, P. J., Lobigs, M., Blanden, R. V. and Gautam, A. M., Nonobese diabetic mice display elevated levels of class II-assocated invariant chain peptide associated with I-Ag7 on the cell surface. J. Immunol. 2001. 166: 4490-4497.
22. Silver, L. M., Mouse genetics: concepts and applications. Oxford University Press, New York 1995.
23. Behlke, M. A., Chou, H. S., Huppi, K. and Loh, D. Y., Murine T cell receptor mutants with deletions of beta-chain variable region genes. Proc. Natl. Acad. Sci. USA 1986. 83: 767-771.
24. McDuffie, M., Schweiger, D., Reitz, B., Ostrowska, A., Knight, A. M. and Dyson, P. J., I-E-independent deletion of V beta 17a+ T cells by Mtv-3 from the nonobese diabetic mouse. J. Immunol. 1992. 148: 2097-2102.
25. Becker, K. G., Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes 1999. 48: 1353-1358.
26. Baker, D., Rosenwasser, O. A., O'Neill, J. K. and Turk, J. L., Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 1995. 155: 4046-4051.
27. Alleva, D. G., Johnson, E. B., Wilson, J., Beller, D. I. and Conlon, P. J., SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. J. Leukoc. Biol. 2001. 69: 440-448.
28. Maron, R., Hancock, W. W., Sevin, A., Hattori, M., Kuchroo, V. and Weiner, H. L., Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int. Immunol. 1999. 11: 1573-1580.
29. Whitham, R. H., Wingett, D., Wineman, J., Mass, M., Wegmann, K., Vandenbark, A. and Offner, H., Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen. J. Neurosci. Res. 1996. 45: 104-116.
30. Whitham, R. H., Bourdette, D. N., Hashim, G. A., Herndon, R. M., Ilg, R. C., Vandenbark, A. A. and Offner, H., Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 1991. 146: 101-107.
31. Stratmann, T., Apostolopoulos, V., Mallet-Designe, V., Corper, A. L., Scott, C. A., Wilson, I. A., Kang, A. S. and Teyton, L., The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 2000. 165: 3214-3225.
32. Boulard, O., Damotte, D., Deruytter, N., Fluteau, G., Carnaud, C. and Garchon, H. J., An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 2002. 51: 2141-2147.
33. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K., An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995. 3: 397-405.
34. Reddy, J., Bettelli, E., Nicholson, L., Waldner, H., Jang, M. H., Wucherpfennig, K. W. and Kuchroo, V. K., Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 2003. 170: 870-877.